Bliss GVS Pharma Share Price

NSE: BLISSGVS
|
Pharmaceuticals

₹ 660.70

-₹10.35 (-1.54%)
1D
Last updated 14 Oct, 2026, 15:55 IST

Bliss GVS Pharma Share Price Today

As of 14 Oct 2026, Bliss GVS Pharma share price is ₹660.70. The stock opened at ₹674.50, compared to its previous close of ₹671.05. During today's trading session, Bliss GVS Pharma share price moved in the range of ₹660.00 to ₹674.50, with an average price of ₹667.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹118.00 and a high of ₹739.90. On the performance front, Bliss GVS Pharma share price has increased by 157.13% over the last six months and is up 333.55% on a year-on-year basis.

₹660.00
1.54% down today
₹674.50
1D LOW
1D HIGH

Bliss GVS Pharma Returns Calculator

Volume
74,905
Average traded price
₹664.96
Last traded time
03:55:48 14 Oct
Last traded quantity
10
Circuit
L
H
₹637.50
₹704.60
52-week
L
H
₹118.00
₹739.90
Mkt Cap Cr
7,136.37
P/E
50.35
P/B
5.98
ROA
9.5%
ROE
10.82%
ROCE
16.48%
Quick Ratio
3.38
EV/EBITDA
28.56
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Bliss GVS Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Bliss GVS Pharma appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Bliss GVS Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0135.035.0811.19%13.74%17.33%2.3121.42
Divis Laboratories2,46,222.1184.1814.6914.6%15.32%19.56%3.556.81
Torrent Pharmaceuticals1,76,300.5081.7720.964.87%25.49%13.85%0.7538.3
Zydus Lifesciences1,12,817.6824.574.168.57%18.59%17.35%0.9115.07
Laurus Labs1,11,898.66101.6420.9110.38%16.77%16.14%0.6854.71
Cipla1,06,129.9632.023.127.92%11.27%14.95%2.517.97
Dr. Reddy's Laboratories1,03,471.1432.52.725.48%11.07%12.54%1.3516.27
Mankind Pharma99,089.5247.326.07.36%11.74%13.13%0.7426.02
Aurobindo Pharma96,836.1026.12.566.34%9.25%11.76%1.1512.57
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.46

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Bliss GVS Pharma

ISIN
INE416D01022
Sector Market Cap
₹ 7,136.37 Cr

Bliss GVS Pharma Limited is engaged in developing, manufacturing, and marketing pharmaceutical formulations. The Company’s product categories include pharma products, other healthcare products, and therapeutic index. Its pharma products include pharma products include capsules, creams, gels, ointments, dry powder for injection, effervescent tablets, eye/ear drops, nasal solution, lotions, lozenges, oral solids, and others. The Company’s other healthcare products include balm, nasal inhaler, solution, soap, roll on, shampoo, powder, spray, and petroleum jelly. Its brands include ANOMEX, ANOMEX DS, CONLAX 5/10, G - ALFENAC 100, GACET 80/125/170/250/500/1G, GMETH - 50/100, GSUNATE - 50/100/200, GVCAM - 7.5/15, GV-SOFT 1/2/3/4 G, LOFNAC - 12.5/25/50/100, MEFINOL, MELANEZ, MENINA - 25/100, TYRIDOL, VIGOTAMIN, COMIT 50, BG - CLIND, VAGID CL, ECOZOLE, GVGYL 500, GYNANFORT, GVGYL N, KLOVINAL, LONART, LONART FORTE, LONART Dispersible, FINMOL, GACET-500, NOVOGLIP-5, GVZOLE, and DOXYCYCLINE.

Bliss GVS Pharma Financial Highlights

  • Revenue: Bliss GVS Pharma reported revenue of ₹1,000.64 crore in FY26 vs ₹846.22 crore in FY25. It showed an increase of 18.25% on a yearly basis.
  • Operating Profit: Bliss GVS Pharma reported an operating profit of ₹189.59 crore in FY26 vs ₹125.64 crore in FY25. It showed an increase of 50.90% on a year-on-year basis.
  • Net Profit: Bliss GVS Pharma reported a net profit of ₹134.73 crore in FY26 vs ₹90.26 crore in FY25. It showed an increase of 49.27% on a yearly basis.

Bliss GVS Pharma Quarterly Result Highlights

  • Bliss GVS Pharma reported revenue of ₹295.18 crore in Jun 2026, compared with ₹268.15 crore in Mar 2026, representing an increase of 10.08% on a quarter-on-quarter (QoQ) basis.
  • Bliss GVS Pharma reported an operating profit of ₹75.48 crore in Jun 2026, compared with ₹44.95 crore in Mar 2026, representing an increase of 67.92% on a quarter-on-quarter (QoQ) basis.
  • Bliss GVS Pharma reported a profit of ₹51.37 crore in Jun 2026, compared with ₹37.00 crore in Mar 2026, reflecting an increase of 38.84% on a QoQ basis.
  • The earnings per share (EPS) of Bliss GVS Pharma stood at ₹12.23 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
35.01%
FII
8.07%
Other DII
9.21%
Retail and other
47.45%
Mutual funds
0.26%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202513.27%
Dec 202514.54%
Mar 202610.45%
Jun 20268.07%
1 day
+0.19%
1 week
-0.80%
1 month
-6.92%
1 year
+333.55%
3 years
+646.86%
5 years
+495.43%
Day
Open / Close
Change %
13 Oct 26
₹672.00 / ₹671.05
+0.19%
12 Oct 26
₹659.90 / ₹669.75
+2.10%
09 Oct 26
₹667.10 / ₹655.95
-1.76%
08 Oct 26
₹693.95 / ₹667.70
-2.03%
Show more

Bliss GVS Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹927.11₹809.73₹770.24₹751.59
Other Income₹73.53₹36.49₹28.74₹17.79
Total Revenue₹1,000.64₹846.22₹798.98₹769.37
Total Expenses₹808.57₹720.58₹652.91₹663.30
Profit Before Tax₹189.59₹125.64₹116.87₹106.07
Tax₹54.86₹35.38₹35.29₹29.34
Profit After Tax₹134.73₹90.26₹81.58₹76.73
EPS - Basic₹12.23₹8.02₹7.23₹6.83
EPS - Diluted₹12.00₹7.95₹7.11₹6.72

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹189.59₹125.64₹146.07₹106.07
Income before WC changes₹285.46₹196.38₹184.24₹163.99
Change in Assets-₹158.32-₹53.98-₹35.62-₹75.86
Change in Liabilities₹53.88₹2.52-₹10.95-₹9.26
Change in WC-₹104.45-₹51.46-₹46.57-₹85.12
Cash flow from Operations₹138.72₹105.91₹102.82₹34.31
Cash flow from Investing-₹38.28-₹75.59-₹83.19-₹7.75
Cash flow from Financing-₹89.21-₹30.20-₹20.89-₹24.94
Total Cash Flow₹11.23₹0.13-₹1.27₹1.62
Cash (Start of the year)₹23.82₹23.59₹25.01₹21.99
Cash (End of the year)₹35.14₹23.82₹23.59₹25.01

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹546.08₹477.46₹400.72₹459.49
Current Assets₹946.34₹823.83₹810.87₹697.37
Total Assets₹1,492.41₹1,301.29₹1,211.59₹1,156.85
Current Liabilities₹235.54₹172.16₹157.41₹193.26
Net Current Asset₹710.79₹651.67₹653.47₹504.11
Non-Current Liabilities₹25.11₹37.28₹51.20₹46.17
Equity Capital₹1,231.76₹1,091.85₹1,002.98₹917.42
Total Equity & Liabilities₹1,492.41₹1,301.29₹1,211.59₹1,156.85

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹729.81₹667.20₹605.46₹598.34
Other Income₹43.72₹36.22₹33.50₹50.77
Total Revenue₹773.53₹703.42₹638.96₹649.11
Total Expenses₹637.91₹609.25₹527.62₹533.41
Profit Before Tax₹133.46₹94.17₹70.26₹115.69
Tax₹36.59₹25.20₹19.61₹30.21
Profit After Tax₹96.87₹68.97₹50.64₹85.48
EPS - Basic₹9.17₹6.56₹4.85₹8.23
EPS - Diluted₹9.00₹6.50₹4.77₹8.10

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹133.46₹94.17₹111.34₹115.69
Income before WC changes₹203.80₹150.61₹155.59₹157.11
Change in Assets-₹82.79-₹23.72-₹31.70-₹67.36
Change in Liabilities₹40.61₹0.64-₹12.38-₹8.23
Change in WC-₹42.18-₹23.08-₹44.08-₹75.58
Cash flow from Operations₹123.16₹97.21₹82.17₹43.81
Cash flow from Investing-₹51.40-₹77.87-₹65.84-₹12.97
Cash flow from Financing-₹75.37-₹26.56-₹20.76-₹26.05
Total Cash Flow-₹3.61-₹7.23-₹4.43₹4.79
Cash (Start of the year)₹6.85₹14.17₹18.60₹13.82
Cash (End of the year)₹3.33₹6.85₹14.17₹18.60

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹517.82₹454.40₹378.04₹410.04
Current Assets₹826.36₹765.74₹772.23₹729.65
Total Assets₹1,344.18₹1,220.14₹1,150.27₹1,139.69
Current Liabilities₹168.59₹125.00₹114.89₹153.36
Net Current Asset₹657.77₹640.74₹657.34₹576.30
Non-Current Liabilities₹20.40₹36.51₹46.94₹49.34
Equity Capital₹1,155.19₹1,058.63₹988.44₹937.00
Total Equity & Liabilities₹1,344.18₹1,220.14₹1,150.27₹1,139.69
* All values are in INR Crore
Qty
Bid
200
660.7
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 200
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
51.65
Neutral
ATR (14)
32.41
Neutral
STOCH(9,6)
41.87
Neutral
STOCH RSI (14)
17.42
Bullish
ADX(9)
23.43
Bearish
UO(9)
46
Neutral
ROC(12)
-2.33
Bearish
WillR(14)
-65.23
Neutral
Period
Simple value
Exponential vaue
5D
669.2
670.48
10D
677.62
675.61
20D
684.94
673.52
50D
619.98
625.66
100D
540.07
543.96
Volume trend — traded volume by day
14 Oct0L
13 Oct2L
12 Oct0L
9 Oct1L
8 Oct1L
7 Oct1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Bliss GVS Pharma
Pharmaceuticals
Add Stock
Add Another

Bliss GVS Pharma Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.